|
|
||||||||



* Laboratory of Molecular Genetics, Hellenic Pasteur Institute, and
Laboratory of Mass Spectrometry and Dioxin Analysis, National Center for Scientific Research Demokritos, Athens, Greece; and
Division of Neuroimmunology, Brain Research Institute, Vienna, Austria
Cellular FLIP (c-FLIP) is an endogenous inhibitor of death receptor-induced apoptosis through the caspase 8 pathway. It is an NF-
B-inducible protein thought to promote the survival of T cells upon activation, and its down-regulation has been implicated in activation-induced cell death. We have generated transgenic mice overexpressing human c-FLIP long form (c-FLIPL) specifically in T cells using the CD2 promoter (TgFLIPL). TgFLIPL mice exhibit increased IgG1 production upon stimulation by a T cell-dependent Ag and a markedly enhanced contact hypersensitivity response to allergen. In addition to showing augmented Th2-type responses, TgFLIPL mice are resistant to the development of myelin oligodendrocyte glycoprotein 3555 peptide-induced experimental autoimmune encephalomyelitis, a Th1-driven autoimmune disease. In vitro analyses revealed that T cells of TgFLIPL mice proliferate normally, but produce higher levels of IL-2 and show preferential maturation of Th2 cytokine-producing cells in response to antigenic stimulation. After adoptive transfer, these (Th2) cells protected wild-type recipient mice from experimental autoimmune encephalomyelitis induction. Our results show that the constitutive overexpression of c-FLIPL in T cells is sufficient to drive Th2 polarization of effector T cell responses and indicate that it might function as a key regulator of Th cell differentiation.
This article has been cited by other articles:
![]() |
N. Zhang, K. Hopkins, and Y.-W. He c-FLIP Protects Mature T Lymphocytes from TCR-Mediated Killing J. Immunol., October 15, 2008; 181(8): 5368 - 5373. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Tseveleki, P. Tsagozis, O. Koutsoni, E. Dotsika, and L. Probert Cellular FLIP long isoform transgenic mice overcome inherent Th2-biased immune responses to efficiently resolve Leishmania major infection Int. Immunol., October 1, 2007; 19(10): 1183 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Charo and P. F. Robbins Contrasting effects of FLIPL overexpression in human T cells on activation-induced cell death and cytokine production J. Leukoc. Biol., May 1, 2007; 81(5): 1297 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. L. Tamma, K. W. Chung, T. Patel, S. P. Balan, and S. Pahwa p38 MAPK plays a role in IL-4 synthesis in jacalin plus CD28-stimulated CD4+ T cells--II J. Leukoc. Biol., June 1, 2006; 79(6): 1339 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Tan, X. Zhou, M. D. Mayes, P. Gourh, X. Guo, C. Marcum, L. Jin, and F. C. Arnett Jr Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients Rheumatology, June 1, 2006; 45(6): 694 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Donlin, N. M. Danzl, C. Wanjalla, and K. Alexandropoulos Deficiency in Expression of the Signaling Protein Sin/Efs Leads to T-Lymphocyte Activation and Mucosal Inflammation Mol. Cell. Biol., December 15, 2005; 25(24): 11035 - 11046. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zhang and Y.-W. He An essential role for c-FLIP in the efficient development of mature T lymphocytes J. Exp. Med., August 1, 2005; 202(3): 395 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Silva, L. V. C. Guillermo, F. L. Ribeiro-Gomes, J. De Meis, R. M. S. Pereira, Z. Wu, T. C. Calegari-Silva, S. H. Seabra, U. G. Lopes, R. M. Siegel, et al. Caspase-8 Activity Prevents Type 2 Cytokine Responses and Is Required for Protective T Cell-Mediated Immunity against Trypanosoma cruzi Infection J. Immunol., May 15, 2005; 174(10): 6314 - 6321. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |